Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1943 2
1947 1
1950 1
1951 1
1952 1
1953 1
1955 1
1957 1
1958 3
1960 1
1961 2
1964 4
1965 2
1966 2
1967 1
1968 3
1969 1
1970 1
1971 7
1972 10
1973 3
1974 5
1975 7
1976 8
1977 8
1978 13
1979 13
1980 15
1981 15
1982 12
1983 19
1984 26
1985 19
1986 26
1987 35
1988 28
1989 24
1990 29
1991 27
1992 25
1993 24
1994 17
1995 30
1996 26
1997 22
1998 29
1999 32
2000 31
2001 41
2002 24
2003 30
2004 37
2005 34
2006 35
2007 35
2008 39
2009 46
2010 41
2011 43
2012 55
2013 48
2014 40
2015 47
2016 43
2017 36
2018 41
2019 32
2020 51
2021 52
2022 28
Text availability
Article attribute
Article type
Publication date

Search Results

1,395 results
Results by year
Filters applied: . Clear all
Page 1
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study.
Overman MJ, McDermott R, Leach JL, Lonardi S, Lenz HJ, Morse MA, Desai J, Hill A, Axelson M, Moss RA, Goldberg MV, Cao ZA, Ledeine JM, Maglinte GA, Kopetz S, André T. Overman MJ, et al. Among authors: moss ra. Lancet Oncol. 2017 Sep;18(9):1182-1191. doi: 10.1016/S1470-2045(17)30422-9. Epub 2017 Jul 19. Lancet Oncol. 2017. PMID: 28734759 Free PMC article. Clinical Trial.
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer.
Overman MJ, Lonardi S, Wong KYM, Lenz HJ, Gelsomino F, Aglietta M, Morse MA, Van Cutsem E, McDermott R, Hill A, Sawyer MB, Hendlisz A, Neyns B, Svrcek M, Moss RA, Ledeine JM, Cao ZA, Kamble S, Kopetz S, André T. Overman MJ, et al. Among authors: moss ra. J Clin Oncol. 2018 Mar 10;36(8):773-779. doi: 10.1200/JCO.2017.76.9901. Epub 2018 Jan 20. J Clin Oncol. 2018. PMID: 29355075 Free article.
Procurement.
Moss RJ, Batista A, Makridaki D, Süle A, Kohl S. Moss RJ, et al. Eur J Hosp Pharm. 2019 May;26(3):173-174. doi: 10.1136/ejhpharm-2018-001822. Epub 2019 May 7. Eur J Hosp Pharm. 2019. PMID: 31428327 Free PMC article. Review.
Transfemoral Transcatheter Tricuspid Valve Replacement With the EVOQUE System: A Multicenter, Observational, First-in-Human Experience.
Fam NP, von Bardeleben RS, Hensey M, Kodali SK, Smith RL, Hausleiter J, Ong G, Boone R, Ruf T, George I, Szerlip M, Näbauer M, Ali FM, Moss R, Bapat V, Schnitzler K, Kreidel F, Ye J, Deva DP, Mack MJ, Grayburn PA, Peterson MD, Leon MB, Hahn RT, Webb JG. Fam NP, et al. Among authors: moss r. JACC Cardiovasc Interv. 2021 Mar 8;14(5):501-511. doi: 10.1016/j.jcin.2020.11.045. Epub 2021 Feb 10. JACC Cardiovasc Interv. 2021. PMID: 33582084 Free article.
H3K4 methylation by SETD1A/BOD1L facilitates RIF1-dependent NHEJ.
Bayley R, Borel V, Moss RJ, Sweatman E, Ruis P, Ormrod A, Goula A, Mottram RMA, Stanage T, Hewitt G, Saponaro M, Stewart GS, Boulton SJ, Higgs MR. Bayley R, et al. Among authors: moss rj. Mol Cell. 2022 May 19;82(10):1924-1939.e10. doi: 10.1016/j.molcel.2022.03.030. Epub 2022 Apr 18. Mol Cell. 2022. PMID: 35439434 Free article.
A CFTR potentiator in patients with cystic fibrosis and the G551D mutation.
Ramsey BW, Davies J, McElvaney NG, Tullis E, Bell SC, Dřevínek P, Griese M, McKone EF, Wainwright CE, Konstan MW, Moss R, Ratjen F, Sermet-Gaudelus I, Rowe SM, Dong Q, Rodriguez S, Yen K, Ordoñez C, Elborn JS; VX08-770-102 Study Group. Ramsey BW, et al. Among authors: moss r. N Engl J Med. 2011 Nov 3;365(18):1663-72. doi: 10.1056/NEJMoa1105185. N Engl J Med. 2011. PMID: 22047557 Free PMC article. Clinical Trial.
Necrotizing enterocolitis.
Dominguez KM, Moss RL. Dominguez KM, et al. Among authors: moss rl. Clin Perinatol. 2012 Jun;39(2):387-401. doi: 10.1016/j.clp.2012.04.011. Epub 2012 May 18. Clin Perinatol. 2012. PMID: 22682387 Review.
1,395 results